We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CMS Says Mylan Paid Generics Rebate for Brand-Name EpiPen
CMS Says Mylan Paid Generics Rebate for Brand-Name EpiPen
For years, Mylan has dodged paying the appropriate rebates for its epinephrine auto-injector EpiPen through a misclassification, the Centers for Medicare and Medicaid Services confirmed.